Cargando…
Overview on Epigenetic Re-programming: A Potential Therapeutic Intervention in Triple Negative Breast Cancers
Breast cancer treatments leads to variable responses. Hormonal therapy is beneficial to receptor positive breast cancer subtypes and display better clinical outcome than triple negative breast cancers (TNBCs) with FEC (5-Fluorouracil, Epirubicin and Cyclophosphamide) the mainstay chemotherapy regime...
Autores principales: | Hanif, Ezanee Azlina Mohamad, Shah, Shamsul Azhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428526/ https://www.ncbi.nlm.nih.gov/pubmed/30583339 http://dx.doi.org/10.31557/APJCP.2018.19.12.3341 |
Ejemplares similares
-
A Cell-Based Systematic Review on the Role of Annexin A1 in Triple-Negative Breast Cancers
por: Pearanpan, Lishantini, et al.
Publicado: (2022) -
Is targeting autophagy mechanism in cancer a good approach? The possible double-edge sword effect
por: Lim, Su Min, et al.
Publicado: (2021) -
Association between MIR499A rs3746444 polymorphism and breast cancer susceptibility: a meta-analysis
por: Tan, Shing Cheng, et al.
Publicado: (2020) -
The rs9340799 polymorphism of the estrogen receptor alpha (ESR1) gene and its association with breast cancer susceptibility
por: Tan, Shing Cheng, et al.
Publicado: (2021) -
Triple Negative Breast Cancer – An Overview
por: Aysola, Kartik, et al.
Publicado: (2013)